Unified Women’s

Unified Women’s Healthcare Addresses Growing Demand for Menopause Care

Unified Women’s Healthcare Responds to Rising Demand for Menopause Care Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for You, its patient resource platform and corresponding awareness campaign, which…

Read MoreUnified Women’s Healthcare Addresses Growing Demand for Menopause Care
Case Study

Case Study Shows CyPath® Lung Reduces Diagnostic Burden in At-Risk Patients

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer bioAffinity Technologies, Inc. a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new…

Read MoreCase Study Shows CyPath® Lung Reduces Diagnostic Burden in At-Risk Patients
Bristol Myers Squibb

NexEos Bio Secures FDA Green Light to Progress NTX-1024 into Phase II/III Clinical Development

NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S.…

Read MoreNexEos Bio Secures FDA Green Light to Progress NTX-1024 into Phase II/III Clinical Development
Dock Health

Dock Health Deploys Workflow Productivity Platform at Mayo Clinic

Dock Health Introduces Its Productivity Platform at Mayo Clinic to Modernize Operational Workflows Dock Health today announced that its productivity platformhas been implemented at Mayo Clinic to automate and optimize operational workflows in its cardiovascular, econsult, and specialty contract programs by transforming manual processes into…

Read MoreDock Health Deploys Workflow Productivity Platform at Mayo Clinic
vedolizumab

Phase 3 Data Support ENTYVIO® (vedolizumab) for Pediatric Moderate to Severe Ulcerative Colitis

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis Takeda today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer the possibility…

Read MorePhase 3 Data Support ENTYVIO® (vedolizumab) for Pediatric Moderate to Severe Ulcerative Colitis
M-Cube

M-Cube, SOLUM Partner to Provide Unified Digital Signage and ESL Solutions for European Retailers

M-Cube and SOLUM Enter Strategic Partnership to Deliver Integrated Digital Signage and ESL Solutions for Retail Across Europe M-Cube and SOLUM have entered into a strategic partnership through a Memorandum of Understanding (MoU) to deliver integrated Digital Signage and e-paper solutions for retail…

Read MoreM-Cube, SOLUM Partner to Provide Unified Digital Signage and ESL Solutions for European Retailers
Hana Health

Hana Health by DSS Imagetech Collaborates with Overture Life to Debut Automated Egg-Freezing Solution in India

Hana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to India For the first time in India, couples seeking In Vitro Fertilisation (IVF) treatment for conception can rely on a globally preferred, automated egg-freezing…

Read MoreHana Health by DSS Imagetech Collaborates with Overture Life to Debut Automated Egg-Freezing Solution in India
Long-Acting

Long-Acting Cabenuva from ViiV Healthcare Demonstrates Superior Results to Oral HIV Regimens in NEJM Study

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today…

Read MoreLong-Acting Cabenuva from ViiV Healthcare Demonstrates Superior Results to Oral HIV Regimens in NEJM Study
CalmWave®

CalmWave® Introduces Recovery State to Support Safer, Earlier Hospital Discharges

CalmWave® Launches Recovery State to Enable Safer, Earlier Hospital Discharge CalmWave, a leader in the safe reduction of non-actionable alarms through healthcare data science and Transparent AI, today announced the launch of Recovery State, a first-of-its-kind solution that uses the…

Read MoreCalmWave® Introduces Recovery State to Support Safer, Earlier Hospital Discharges
Daffodil Health

Daffodil Health Secures $16.3M Series A to Reduce Health Plans’ Dependence on Percent-of-Savings Middlemen

Daffodil Health Raises $16.3M Series A to Break Health Plans’ Reliance on Percent-of-Savings Middlemen Daffodil Health, an AI-powered platform modernizing U.S. health plan administration and claims processing, today announced it has raised $16.3 million, bringing its total funds raised to…

Read MoreDaffodil Health Secures $16.3M Series A to Reduce Health Plans’ Dependence on Percent-of-Savings Middlemen